methantheline has been researched along with Postgastrectomy Syndromes in 1 studies
Methantheline: A quaternary ammonium compound that acts as an antimuscarinic agent. It has been used in the treatment of PEPTIC ULCER, in gastrointestinal disorders associated with smooth muscle spasm, and in the management of urinary incontinence, and may also be used for the treatment of HYPERHIDROSIS.
Postgastrectomy Syndromes: Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FREELING, P | 1 |
1 other study available for methantheline and Postgastrectomy Syndromes
| Article | Year |
|---|---|
A TRIAL OF OXYPHENCYCLIMINE, A NEW ANTICHOLINERGIC AGENT.
Topics: Biomedical Research; Cholinergic Antagonists; Duodenal Ulcer; Dyspepsia; Hernia, Diaphragmatic; Huma | 1964 |